← Back to Search

Cannabinoid

CBD Oil for Inflammation in HIV (cannabis Trial)

Phase 4
Waitlist Available
Led By Simone Marini, PhD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up two time points considered: baseline, and after 1 month (1 individual) or 2 months (2 individuals)
Awards & highlights

cannabis Trial Summary

This trial will study the effects of CBD on inflammation in PLWH, and establish the molecular role of different immune cells in this process.

Who is the study for?
This trial is for people over 21 and under 60 living with HIV, on antiretroviral therapy for at least five years with a suppressed viral load. They must be willing to take CBD oil and follow up for two months. It excludes University of Florida staff/students, those with certain health conditions or taking medications affecting the immune system, pregnant individuals, and current marijuana/CBD users.Check my eligibility
What is being tested?
The study investigates how CBD oil affects chronic inflammation in people living with HIV. Researchers will analyze blood samples using advanced techniques to see if there are changes in immune cells after taking CBD.See study design
What are the potential side effects?
While not explicitly listed in the provided information, common side effects of CBD may include tiredness, diarrhea, changes in appetite/weight. However, specific side effects related to this trial's population will be monitored.

cannabis Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~two time points considered: baseline, and after 1 month (1 individual) or 2 months (2 individuals)
This trial's timeline: 3 weeks for screening, Varies for treatment, and two time points considered: baseline, and after 1 month (1 individual) or 2 months (2 individuals) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Differentially Expressed Genes

Side effects data

From 2022 Phase 4 trial • 4 Patients • NCT05209867
25%
Neck pain
100%
80%
60%
40%
20%
0%
Study treatment Arm
CBD Intervention

cannabis Trial Design

1Treatment groups
Experimental Treatment
Group I: CBD InterventionExperimental Treatment1 Intervention
Participants will self-administer CBD daily for 2 months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CBD oil
2022
Completed Phase 4
~10

Find a Location

Who is running the clinical trial?

Consortium for Medical Marijuana Clinical Outcomes ResearchOTHER
4 Previous Clinical Trials
112 Total Patients Enrolled
University of FloridaLead Sponsor
1,340 Previous Clinical Trials
715,701 Total Patients Enrolled
1 Trials studying Chronic Inflammation
180 Patients Enrolled for Chronic Inflammation
Simone Marini, PhDPrincipal InvestigatorUniversity of Florida

Media Library

CBD oil (Cannabinoid) Clinical Trial Eligibility Overview. Trial Name: NCT05209867 — Phase 4
Chronic Inflammation Research Study Groups: CBD Intervention
Chronic Inflammation Clinical Trial 2023: CBD oil Highlights & Side Effects. Trial Name: NCT05209867 — Phase 4
CBD oil (Cannabinoid) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05209867 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what degree can CBD oil be utilized safely by patients?

"We rate the safety of CBD oil to be 3 on a scale from 1 to 3 due to it being in the fourth phase of clinical trials, indicating that this is an approved medication."

Answered by AI

Am I a suitable candidate to become part of this research project?

"This medical trial seeks 7 participants aged 21 to 60 years old, who are afflicted with inflammation and comply with the additional criteria: taking CBD as prescribed, participating in follow-up for two months, on antiretroviral therapy for more than five years and having a CD4 count lower than 350cells/ml."

Answered by AI

How many participants have signed up to join this trial?

"Affirmative. According to clinicaltrials.gov, the trial first went up on May 1st 2022 and was recently updated on September 15th 2022; this medical experiment is presently recruiting for 7 subjects at a single site of care."

Answered by AI

Is the age limit for participants in this investigation restricted to individuals under 55 years old?

"The eligibility criteria for this clinical trial indicates that potential participants must between 21 and 60 years of age. Separately, there are 27 trials open to those under 18 while 266 studies cater towards seniors over 65."

Answered by AI

Is there availability for any new patients to participate in this trial?

"Affirmative. Clinicaltrials.gov presents data attesting to the fact that this research is still enrolling participants, with initial postings dating back to May 1st 2022 and more recent updates on September 15th 2022. The study requires 7 individuals at a single site."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Single-cell CBD Biomarkers of Inflammation Reduction in People Living With HIV
2022. "Single-cell CBD Biomarkers of Inflammation Reduction in People Living With HIV". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05209867.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top